Establishment and evaluation of trimester-specific reference intervals for thyroid tests during pregnancy in Foshan
-
摘要:
目的建立广东省佛山市妊娠期特异血清甲状腺指标参考值范围,并对妊娠期甲状腺疾病患病率进行评价。 方法回顾性分析2017年6月~2018年6月在佛山市产检孕妇的血清甲状腺指标,包括促甲状腺激素(TSH)、游离甲状腺素(FT4)、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TgAb)。根据美国临床生化研究院标准,筛选出样本量1386例,建立妊娠三期特异参考值范围。 结果妊娠特异TSH和FT4参考值范围分别为0.03~3.86 mU/L、11.81~21.86 pmol/L(孕早期);0.13~4.50 mU/L、11.75~20.99 pmol/L(孕中期);0.38~4.73 mU/L、10.84~18.48 pmol/L(孕晚期)。采用上述妊娠期特异甲状腺指标参考值范围,计算甲减、亚临床甲减、甲亢、亚临床甲亢的患病率分别为0%、0.93%、0.93%、1.55%(孕早期);0%、1.29%、1.29%、3.23%(孕中期);0%、2.11%、0.55%、2.39%(孕晚期)。与试剂盒参考值范围比较,只有妊娠早期甲亢及三期亚临床甲亢患病率有统计学差异。 结论佛山市妊娠期特异血清甲状腺指标参考值范围的建立,为本地区妊娠甲状腺疾病的诊断提供了临床依据。试剂盒的甲状腺指标参考值范围可用于佛山市临床甲减、亚临床甲减的诊断,但不适合应用于佛山市甲亢、亚临床甲亢的诊断。 Abstract:ObjectiveTo establish the trimester-specific reference intervals of thyroid tests during pregnancy in Foshan, Guangdong, then to evaluate the prevalence of gestational thyroid diseases. MethodsThe medical records of pregnant women with took prenatal care in Foshan from Jun 2017 to Jun 2018 were retrospectively analyzed. The thyriod tests included TSH, FT4, TPOAb, TgAb. All pregnant women were screened according to the National Academy of Clinical Biochemistry (NACB) recommendations. A total of 1386 samples at different stages of gestation were selected for setting reference intervals, which were 2.5th-97.5th. ResultsThe TSH and FT4 trimester-specific reference intervals were 0.03-3.86 mU/L, 11.81-21.86 pmol/L(1st trimester); 0.13-4.50 mU/L, 11.75-20.99 pmol/L(2nd trimester); and 0.38-4.73 mU/L, 10.84-18.48 pmol/L(3rd trimester), respectively. The prevalence of clinical hypothyroidism, subclinical hypothyroidism, hyperthyroidism, subclinical hyperthyroidism were 0%, 0.93%, 0.93%, and 1.55%(1st trimester); 0%, 1.29%, 1.29%, 3.23%(2nd trimester); 0%, 2.11%, 0.55%, 2.39%(3rd trimester), respectively. There were significant differences between trimester-specific thyroid function reference intervals and the reference range of the kit on the prevalence of hyperthyroidism during 1st trimester and subclinical hyperthyroidism during 1st-3rd trimester. ConclusionThe establishment of trimester-specific thyroid function reference intervals of Foshan city provides a clinical basis for the diagnosis of gestational thyroid diseases. The thyroid tests reference range of the kit can be used for the diagnosis of clinical hypothyroidism and subclinical hypothyroidism, while it is not suitable for the diagnosis of hyperthyroidism and subclinical hyperthyroidism in foshan city. -
表 1 妊娠期特异甲状腺指标参考值范围
指标 孕期 n 百分位数 P 2.5 P 97.5 TSH T1期 206 0.03 3.86 T2期 239 0.13 4.50 T3期 941 0.38 4.73 FT4 T1期 206 11.81 21.86 T2期 239 11.75 20.99 T3期 941 10.84 18.48 表 2 T1期不同参考值范围妊娠期甲状腺疾病患病率[n(%)]
参考值标准 甲减 亚临床甲减 甲亢 亚临床甲亢 本研究标准 0(0.00) 3(0.93) 3(0.93) 5(1.55) 试剂盒 0(0.00) 1(0.31) 13(4.02)* 70(21.67)* 腾卫平标准 0(0.00) 2(0.62) 5(1.55) 10(3.10) *P<0.05. 表 4 T3期不同参考值范围妊娠期甲状腺疾病患病率[n(%)]
参考值标准 甲减 亚临床甲减 甲亢 亚临床甲亢 本研究标准 0(0.00) 23(2.11) 6(0.55) 26(2.39) 试剂盒 0(0.00) 22(2.02) 2(0.18) 44(4.04)* *P<0.05. 表 3 T2期不同参考值范围妊娠期甲状腺疾病患病率[n(%)]
参考值标准 甲减 亚临床甲减 甲亢 亚临床甲亢 本研究标准 0(0.00) 6(1.29) 6(1.29) 15(3.23) 试剂盒 0(0.00) 6(1.29) 9(1.94) 82(17.63)* *P<0.05. -
[1] 向红丁. 威廉姆斯内分泌学[M]. 北京: 人民军医出版社, 2013: 323-4. [2] 中华医学会内分泌学分会, 中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J]. 中华内分泌代谢杂志, 2012, 28(5): 354-71. doi: 10.3760/cma.j.issn.1000-6699.2012.05.002 [3] Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines.Laboratory suport for the diagnosis and monitoring of thyroid disease[J]. Thyroid, 2003, 13(1): 3-126. doi: 10.1089/105072503321086962 [4] Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women[J]. J Clin Endocrinol Metab, 2014, 99(1): 73-9. doi: 10.1210/jc.2013-1674 [5] Bestwick JP, John R, Maina A, et al. Thyroid stimuIating hormone and free thyroxine in pregnancy:expressing concentrations as multiples of the median(MoMs)[J]. Clin Chim Acta, 2014, 430(2): 33-7. [6] 许诗珺, 范建霞, 杨 帅, 等. 不同促甲状腺激素和游离甲状腺素检测试剂对妊娠期甲状腺功能检测结果的影响[J]. 中华围产医学杂志, 2015, 18(2): 81-6. doi: 10.3760/cma.j.issn.1007-9408.2015.02.001 [7] Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J]. Thyroid, 2017, 27(3): 315-89. doi: 10.1089/thy.2016.0457 [8] Han LC, Zheng W, Zhai YH, et al. Reference intervals of trimester-specific thyroid stimulating hormone and free thyroxine in Chinese women established by experimental and statistical methods[J]. J Clin Lab Anal, 2018, 32(4): e22344-57. doi: 10.1002/jcla.2018.32.issue-4 [9] Xing JF, Yuan EW, Li J, et al. Trimester- and assay-specific thyroid reference intervals for pregnant women in China[J]. Int J Endocrinol, 2016, 28(11): 3754213-25. [10] Shen FX, Xie ZW, Lu SM, et al. Gestational thyroid reference intervals in antibody-negative Chinese women[J]. Clin Biochem, 2014, 47(7/8): 673-5. [11] 宋晓平, 隋 霜. 迪丽胡马•吐尔逊 乌鲁木齐市妊娠早中晚期甲状腺激素水平的参考范围[J]. 中国妇幼健康研究, 2017, 7(7): 832-5. doi: 10.3969/j.issn.1673-5293.2017.07.026 [12] 王蕴慧, 张 培, 赵会丹, 等. 妊娠期特异性甲状腺功能正常参考值范围[J]. 中山大学学报:医学科学版, 2013, 34(6): 996-1000. [13] Zhang J, Li W, Li W, et al. Establishment of trimester-specific thyroid stimulating hormone and free thyroxine reference interval in pregnant Chinese women using the Beckman Coulter UniCel (TM) DxI 600[J]. Clin Chem Lab Med, 2015, 53(9): 1409-14. [14] 黄文宇. 广东中山地区正常妊娠女性甲状腺功能指标的检测及其临床意义[J]. 广东医科大学学报, 2017, 35(3): 291-4. doi: 10.3969/j.issn.1005-4057.2017.03.020 [15] 刘伟玲, 刘伟旗, 胡 河, 等. 孕妇及新生儿游离甲状腺素和促甲状腺激素参考区间的探讨[J]. 国际检验医学杂志, 2016, 37(11): 1554-6. doi: 10.3969/j.issn.1673-4130.2016.11.046 [16] Levie D, Korevaar T, Bath SC, et al. Thyroid function in early pregnancy,child IQ,and autistic traits:a meta-analysis of individual-participant data[J]. J Clin Endocrinol Metab, 2018, 103(8): 2967-79. doi: 10.1210/jc.2018-00224 [17] Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function[J]. N Engl J Med, 2012, 366(6): 493-501. doi: 10.1056/NEJMoa1106104 [18] Casey BM, Thom EA, Peaceman AM, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy[J]. N Engl J Med, 2017, 376(9): 815-25. doi: 10.1056/NEJMoa1606205 [19] Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child[J]. N Engl J Med, 1999, 341(8): 549-55. doi: 10.1056/NEJM199908193410801 [20] Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy[J]. Am J Obstet Gynecol, 2004, 190(1): 211-7. doi: 10.1016/S0002-9378(03)00944-X